Stock Analysis on Net
Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

This company has been moved to the archive! The financial data has not been updated since May 1, 2025.

Common-Size Income Statement
Quarterly Data

CVS Health Corp., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Products 61.31 63.86 62.90 61.88 61.06 69.65 68.50 68.29 68.45 71.43 71.20 70.56 68.51 70.80 70.50 69.86 68.88 71.56 71.41 71.14 70.58
Premiums 34.89 31.88 32.59 33.76 34.54 26.81 27.55 28.32 28.67 25.66 25.94 26.41 28.22 25.19 25.81 26.25 27.56 25.42 25.70 25.98 26.49
Services 3.80 4.26 4.51 4.36 4.40 3.54 3.95 3.38 2.88 2.91 2.86 3.03 3.27 4.01 3.69 3.90 3.57 3.03 2.89 2.88 2.93
Revenues from customers 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Cost of products sold -54.28 -57.00 -55.81 -55.04 -54.64 -61.38 -61.11 -60.39 -60.58 -61.93 -62.21 -61.24 -59.37 -60.83 -61.20 -60.17 -59.44 -61.25 -61.24 -61.76 -60.59
Health care costs -30.97 -30.47 -31.54 -30.66 -31.60 -24.07 -24.02 -24.57 -24.07 -21.92 -21.52 -21.87 -23.42 -21.74 -21.86 -21.98 -22.83 -21.85 -21.53 -18.03 -21.60
Cost of revenues -85.25% -87.47% -87.34% -85.70% -86.24% -85.45% -85.14% -84.96% -84.65% -83.85% -83.73% -83.11% -82.78% -82.57% -83.06% -82.16% -82.26% -83.11% -82.77% -79.80% -82.19%
Gross profit 14.75% 12.53% 12.66% 14.30% 13.76% 14.55% 14.86% 15.04% 15.35% 16.15% 16.27% 16.89% 17.22% 17.43% 16.94% 17.84% 17.74% 16.89% 17.23% 20.20% 17.81%
Net investment income 0.55 0.78 0.58 0.43 0.52 0.29 0.31 0.31 0.39 0.39 0.25 0.18 0.22 0.48 0.33 0.40 0.43 0.36 0.31 0.28 0.24
Operating expenses -11.72 -10.75 -11.13 -11.38 -11.70 -11.23 -11.04 -11.14 -11.28 -11.44 -11.87 -11.39 -12.88 -13.20 -12.52 -12.26 -12.97 -13.61 -12.67 -13.30 -12.86
Restructuring charges 0.00 -0.01 -1.23 0.00 0.00 0.00 -0.01 -0.56 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Opioid litigation charges 0.00 -0.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.70 -6.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Loss on assets held for sale 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.41 -0.06 -3.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Store impairments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.78 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill impairment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.59 0.00 0.00 0.00 0.00 0.00 0.00
Operating income (loss) 3.59% 2.44% 0.88% 3.35% 2.58% 3.61% 4.12% 3.65% 4.06% 4.33% -4.86% 5.68% 4.55% 2.92% 4.16% 5.98% 5.20% 3.64% 4.86% 7.18% 5.19%
Interest expense -0.83 -0.78 -0.79 -0.81 -0.81 -0.74 -0.77 -0.77 -0.69 -0.66 -0.70 -0.72 -0.76 -0.80 -0.82 -0.88 -0.95 -0.98 -1.09 -1.17 -1.10
Gain (loss) on early extinguishment of debt 0.00 0.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.12 -0.49 0.00 0.00 -0.97 -1.15 0.00 0.00
Other income 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.03 0.05 0.05 0.05 0.05 0.05 0.07 0.06 0.07 0.08 0.08 0.07 0.08
Income (loss) before income tax (provision) benefit 2.78% 2.19% 0.11% 2.57% 1.80% 2.89% 3.37% 2.90% 3.39% 3.72% -5.50% 5.01% 3.84% 2.06% 2.92% 5.16% 4.32% 1.77% 2.70% 6.08% 4.17%
Income tax (provision) benefit -0.89 -0.52 -0.04 -0.63 -0.52 -0.70 -0.84 -0.74 -0.87 -0.97 1.29 -1.33 -0.83 -0.36 -0.76 -1.31 -1.08 -0.35 -0.88 -1.49 -1.15
Income (loss) from continuing operations 1.89% 1.67% 0.07% 1.95% 1.28% 2.19% 2.53% 2.16% 2.52% 2.75% -4.21% 3.68% 3.02% 1.70% 2.16% 3.86% 3.23% 1.42% 1.82% 4.58% 3.02%
Loss from discontinued operations, net of tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00
Net income (loss) 1.89% 1.67% 0.07% 1.95% 1.28% 2.19% 2.53% 2.16% 2.52% 2.75% -4.21% 3.68% 3.02% 1.70% 2.16% 3.86% 3.23% 1.41% 1.82% 4.58% 3.02%
Net (income) loss attributable to noncontrolling interests 0.00 0.02 0.02 0.00 -0.01 0.00 0.00 -0.01 -0.01 0.00 -0.01 -0.01 0.00 0.01 0.01 -0.01 0.00 0.00 0.01 -0.02 -0.01
Net income (loss) attributable to CVS Health 1.89% 1.70% 0.09% 1.95% 1.27% 2.19% 2.53% 2.14% 2.51% 2.76% -4.22% 3.67% 3.02% 1.71% 2.17% 3.85% 3.23% 1.40% 1.83% 4.57% 3.01%

Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).

The financial trajectory from early 2020 through early 2025 is characterized by a fundamental shift in the revenue composition and a corresponding compression of profit margins. There is a clear transition in the business model, with a decreasing reliance on product-based revenue and an increasing dependence on insurance premiums, which has introduced higher volatility in cost structures and overall net profitability.

Revenue Composition Trends
A structural pivot in revenue streams is evident. Product revenues, which accounted for approximately 70% to 71% of total revenues between 2020 and 2022, declined significantly to a range of 61% to 63% by 2024 and 2025. Conversely, premium revenues grew from approximately 25% to 26% in the 2020-2022 period to between 31% and 34% in the final quarters of the analysis. Service-based revenues remained a minor component but showed a slight increase from roughly 3% to 4% over the observed period.
Cost of Revenue and Margin Analysis
The cost of revenues has generally trended upward, moving from roughly 82% in 2020 to peak at 87.47% in late 2024. This is primarily driven by a substantial increase in health care costs, which rose from an average of 21% to 22% in the early periods to over 30% starting in early 2024. While the cost of products sold as a percentage of revenue decreased from approximately 61% to 54% over the same timeframe, this improvement was insufficient to offset the rising health care costs. Consequently, gross profit margins experienced a gradual decline from approximately 17-18% in 2020 to between 12% and 14% in the later periods.
Operating Performance and Non-Recurring Charges
Operating income exhibits significant volatility, particularly in 2022. A sharp decline to -4.86% of revenue occurred in the third quarter of 2022, largely attributable to opioid litigation charges totaling 6.45% and losses on assets held for sale. Other non-recurring pressures include store impairments in late 2021 and periodic restructuring charges. Despite these disruptions, operating expenses as a percentage of revenue showed a slight downward trend, improving from approximately 13% in 2020 to roughly 11% by 2024, indicating a degree of operational efficiency in overhead management.
Net Profitability and Bottom-Line Results
Net income attributable to the parent company has trended downward over the five-year period. From a peak of 4.57% in mid-2020, the net margin generally settled into a range of 1.2% to 2.5% by 2024 and 2025. The volatility in the bottom line is closely tied to the aforementioned litigation charges and the shifting cost of health care delivery. Net investment income provided a minor but consistent positive contribution, generally ranging between 0.2% and 0.7% of revenues, providing a slight buffer against operating losses.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?